MedTrace Logo

Ashwagandha for Nighttime Waking

NCT07151261 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-03-16

No results posted yet for this study

Summary

The purpose of this research is to evaluate the effect of a sustained-release, lower-dosage (150mg) Ashwagandha supplement to reduce disturbed sleep. 54 participants, after randomization, will take either an Ashwagandha supplement or a placebo daily for 28 days (week 4) and wear an Oura ring. The Oura ring will measure waking after sleep onset (WASO). Questionnaires to evaluate quality of life and sleep will be administered at baseline and week 4.

Conditions

  • Disturbed Sleep

Interventions

DIETARY_SUPPLEMENT

Ashwagandha

Sustained-Release, lower-dosage (150mg) Ashwagandha Supplement, 1 capsule 1 time per day.

OTHER

Placebo

This placebo does not contain any of the interventional dietary supplement. The placebo consists of microcrystalline cellulose and is matched for shape, color, and smell. 1 capsule, 1 time per day.

Sponsors & Collaborators

  • National University of Natural Medicine

    lead OTHER

Principal Investigators

  • Joshua Goldenberg, ND · National University of Natural Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-20
Primary Completion
2026-05-01
Completion
2026-05-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07151261 on ClinicalTrials.gov